Pediatric food allergy prevalence and trends by race and ethnicity

Francesca B Rose1,2, Tyler M Rose3

  • 1Marriott School of Business at Brigham Young University, George W. Romney Institute of Public Service and Ethics, 730 TNRB Brigham Young University, USA.

Asia Pacific Allergy
|September 11, 2025
PubMed

Insights

Asian/Pacific Islander children face higher food allergy risks. This study analyzed over 298,000 pediatric patients, revealing significant disparities in food allergy prevalence and diagnosis rates among racial and ethnic groups in the US.

Area of Science:

  • Pediatric Allergy and Immunology
  • Public Health Disparities
  • Epidemiology

Background:

  • Food allergies (FAs) disproportionately impact children based on race and ethnicity in the US.
  • Existing literature shows gaps and discrepancies regarding FA prevalence across diverse demographic groups.

Purpose of the Study:

  • To analyze clinical data to determine how FA prevalence varies by race and ethnicity.
  • To track trends in FA diagnosis rates over time within different racial and ethnic pediatric populations.

Main Methods:

  • Analysis of clinical data from 298,476 pediatric patients, including FA diagnoses, birth years, and self-reported race/ethnicity.
  • Calculation of odds ratios (OR) for FA by race/ethnicity, controlling for sex, insurance, and birth year.
  • Examination of specific allergen prevalence and trends in FA diagnoses across birth cohorts.

Main Results:

  • Asian/Pacific Islander (A/PI) children exhibited the highest odds of FA (OR, 1.92) and multiple FAs (OR, 1.55).
  • Allergen profiles differed, with A/PI children showing increased odds for peanut, egg, wheat, and sesame allergies compared to White children.
  • FA diagnoses increased until the 2004 birth cohort, stabilizing through the 2008 cohort.

Conclusions:

  • Clinicians and researchers must recognize the elevated risk of FA in A/PI children.
  • Further research is needed to include diverse demographics and monitor long-term FA trends.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Surveys02:16

Surveys

Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
16.6K